Feline Cancer Blood Tests

Volition Expands Blood-Based Cancer Screening for Cats in Japan

Feline cancer blood tests are advancing as VolitionRx expands its partnership with Fujifilm Vet Systems to develop a new screening option for cats in Japan. The Nu.Q Vet Feline Test aims to identify cancer through a simple, affordable blood sample, potentially making earlier detection more accessible during routine veterinary examinations.

The technology builds on Volition's existing canine cancer test, introduced in Japan in July 2024. Initial research involving the feline prototype reported high accuracy in detecting lymphoma, a common cancer among cats. Further studies with Japanese veterinary oncologists are planned before the test launches on the IDS i10 automated analyzer.

For Volition, expanding into feline diagnostics presents revenue opportunities within Japan's market of nearly nine million cats. Fujifilm could also strengthen its veterinary testing services, while clinics may eventually gain a convenient screening option that supports earlier diagnosis and preventive pet healthcare.

Image Credit: AI-generated

Blood-based Pet Screening
Affordable blood draws are reshaping veterinary diagnostics by making routine cancer screening more accessible for companion animals.
Automated Veterinary Diagnostics
Clinic-ready analyzer platforms create openings for faster, scalable testing workflows that reduce reliance on specialized lab infrastructure.
Preventive Feline Healthcare
Earlier disease detection supports a shift from reactive treatment toward ongoing wellness management for aging cat populations.

Who This Affects Most

Veterinary Diagnostics
New companion animal assays expand the market for specialized diagnostic tools that deliver clinical insights from simple biological samples.
Pet Healthcare
Rising demand for preventive care introduces opportunities for services that combine routine exams, screening, and long-term disease monitoring.
Animal Biotechnology
Cross-species biomarker development enables companies to adapt proven testing platforms for underserved veterinary disease categories.
SCORE
6.0 out of 10
GENDER
50% Men50% Women
MARKETTop markets: Asia
GENERATION
  • Gen Z
  • Gen Alpha
  • Millennial (primary audience)
  • Gen X (primary audience)
POPULARITY
Popularity 35%
Activity 45%
Freshness 99%